Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Hepatitis

  Free Subscription


29.06.2026

1 AIDS
4 BMC Gastroenterol
1 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
1 Gut
1 J Clin Microbiol
1 J Interferon Cytokine Res
1 J Viral Hepat
2 JAMA
6 PLoS One
1 Proc Natl Acad Sci U S A
1 Transplant Proc
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. LAPADULA G, Soria A, Puoti M, Bonfanti P, et al
    Occult hepatitis B and risk of reactivation following switch to non-hepatitis B virus-active antiretroviral therapy in people with HIV.
    AIDS. 2026;40:1053-1066.
    PubMed         Abstract available


    BMC Gastroenterol

  2. MOHANTY A, Stead AE, Telep LE, Singer AW, et al
    Hepatocellular carcinoma risk reduction associated with antiviral treatment in patients with noncirrhotic chronic hepatitis B: a systematic literature review and comparative meta-analysis.
    BMC Gastroenterol. 2026 Jun 26. doi: 10.1186/s12876-026-04996.
    PubMed         Abstract available

  3. HAGIWARA S, Matsubara T, Omaru N, Okai N, et al
    Curative treatment is feasible for recurrent hepatocellular carcinoma regardless of recurrence pattern after hepatitis C virus eradication with interferon-free direct-acting antiviral therapy.
    BMC Gastroenterol. 2026 Jun 22. doi: 10.1186/s12876-026-05006.
    PubMed         Abstract available

  4. FUJII H, Nishimura T, Kimura H, Mitsumoto Y, et al
    A novel scoring system to identify patients at low risk for hepatocellular carcinoma five years after DAA-Induced sustained virological response: a retrospective cohort study.
    BMC Gastroenterol. 2025;25:835.
    PubMed         Abstract available

  5. WANG M, Zhou Q, Wu H, Wang Y, et al
    Efficacy of extracorporeal immunoadsorption therapy for removal of HBsAg.
    BMC Gastroenterol. 2025;25:449.
    PubMed         Abstract available


    Dig Dis Sci

  6. AGGARWAL A, Biswas S, Saxena S, Agarwal A, et al
    Recompensation and Further Decompensation After Index Decompensation in Patients with Autoimmune Hepatitis: A Real-World Study.
    Dig Dis Sci. 2026 Jun 22. doi: 10.1007/s10620-026-10056.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  7. SANEKOMMU H, Dandu S, Jayaswal SK, Ozkan MC, et al
    Atrial fibrillation in patients with alcohol-associated hepatitis leads to increased mortality.
    Eur J Gastroenterol Hepatol. 2026;38:971-976.
    PubMed         Abstract available


    Gut

  8. WANG B, Li Y, Li F, Feng Y, et al
    Functional anti-preS1 antibody responses associated with viral control in chronic hepatitis B.
    Gut. 2026 Jun 22:gutjnl-2025-337810. doi: 10.1136/gutjnl-2025-337810.
    PubMed         Abstract available


    J Clin Microbiol

  9. STEPANYANTS V, Hallock E, Doud MK, Harrington E, et al
    Risk assessment and mitigation of hepatitis C virus RNA carryover contamination in a reflex testing algorithm.
    J Clin Microbiol. 2026 Jun 25:e0025626. doi: 10.1128/jcm.00256.
    PubMed         Abstract available


    J Interferon Cytokine Res

  10. TAUFIQ I, Naveed H, Amin I, Shahid M, et al
    Genetic Profiling of Interleukin Variants and their Correlation with Hepatitis C Viral Response to Different Therapeutic Strategies Administered in Pakistani Patients.
    J Interferon Cytokine Res. 2026;46:153-162.
    PubMed         Abstract available


    J Viral Hepat

  11. LAKIOTAKI D, Papatheodoridi M, Sevastianos V, Zachou K, et al
    HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis D.
    J Viral Hepat. 2026;33:e70201.
    PubMed         Abstract available


    JAMA

  12. DYSART K, Ruan AB, Burris HH
    Trends in Newborn Hepatitis B Virus Vaccination.
    JAMA. 2026 Jun 22. doi: 10.1001/jama.2026.6521.
    PubMed        

  13. ROTHMAN JM, Kwan B, Jena AB
    Trends in Newborn Hepatitis B Virus Vaccination-Reply.
    JAMA. 2026 Jun 22. doi: 10.1001/jama.2026.6524.
    PubMed        


    PLoS One

  14. LIN YJ, Kuo CC, Lai CC, Chen HA, et al
    Direct-acting antiviral therapy is associated with a reduced risk of selected immune-mediated inflammatory diseases in chronic hepatitis C infection: A real-world cohort study.
    PLoS One. 2026;21:e0351973.
    PubMed         Abstract available

  15. JESPERSEN S, Fritt-Rasmussen A, Durrer CG, Fallentin E, et al
    Effect of high-intensity interval training in patients with chronic hepatitis B and hepatic steatosis: A randomised controlled trial.
    PLoS One. 2026;21:e0351547.
    PubMed         Abstract available

  16. ACOSTA L, Soldevila N, Torner N, Avellon A, et al
    Modelling Hepatitis B virus related hospital discharges in Spain: ARIMAX based liver disease forecasting tool for hospital workload and mortality progression.
    PLoS One. 2026;21:e0329751.
    PubMed         Abstract available

  17. DEMEKE AD, Tsegaye A, Bayable A, Tamir T, et al
    An umbrella review navigating the nationwide burden of hepatitis B virus infection in Ethiopia: A call for action on vaccination, safe blood, and infection prevention.
    PLoS One. 2026;21:e0352169.
    PubMed         Abstract available

  18. BUGSSA G, Berhe N, Medhin G, Nayagam S, et al
    Biomarkers of chronic liver disease and their determinants in northern Ethiopia: Evaluating the synergistic impact of HBV and Schistosoma mansoni and the contribution of metabolic and lifestyle factors to liver injury.
    PLoS One. 2026;21:e0352266.
    PubMed         Abstract available

  19. DA SILVA MARQUES M, de Neri Machado F, Amaral Mali M, da Costa Sarmento N, et al
    Case-control study of risk factors for abscess development following hepatitis B vaccination in children in Timor-Leste, 2024.
    PLoS One. 2026;21:e0351879.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  20. NIKLASCH M, Wingert I, Fogeron ML, Nassal M, et al
    Hepatitis B virus genome packaging and replication are coordinated by a polymerase-responsive RNA switch in the RNA element epsilon.
    Proc Natl Acad Sci U S A. 2026;123:e2537974123.
    PubMed         Abstract available


    Transplant Proc

  21. REFAEY A, Attia A, Mokhtar F, Saadi O, et al
    Increasing Access to Kidney Transplantation in an Underserved Population Through a Public-Private Partnership Utilizing Hepatitis C Virus-Infected Donors.
    Transplant Proc. 2026 Jun 20:S0041-1345(26)00309.
    PubMed         Abstract available


    Virology

  22. YOUSSEF M, Dopke M, Ginkel C, Ye K, et al
    Augmenting hepatitis C E1E2 glycoprotein antibody detection via an alternative lectin-assisted mannose-binding ELISA.
    Virology. 2026;623:111011.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum